Bioavailable testosterone reduces the risk of lung squamous cell carcinoma: a comprehensive data study
Jihang Luo, Puyu Liu, Jian Song, Yin Li, Meng Xu · 2025
Read Bioavailable testosterone reduces the risk of lung squamous cell carcinoma: a comprehensive data study by Jihang Luo, Puyu Liu, Jian Song, Yin Li, Meng Xu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12860008.txt.
Description
Jihang Luo, Puyu Liu, Jian Song, Yin Li, and Meng Xu studied testosterone and one lung cancer type in a 2025 data study. Links between the hormone and lung cancer were unclear. The team focused on the active, bioavailable share of testosterone and on the squamous cell subtype.
Genetic analyses suggested higher bioavailable testosterone lowers the risk of this subtype, while total testosterone and its binding protein showed no clear link. Reverse analysis found no effect of cancer on hormone levels. In ninety patients, tumours expressing the hormone's receptor came with longer survival, and receptor presence independently predicted better outcomes. The authors flag limits, including mixed ancestry between data sets, and propose both measures as candidate markers.
Catalog record
| CREATOR | Jihang Luo, Puyu Liu, Jian Song, Yin Li, Meng Xu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |